Vanda Pharmaceuticals Inc.
VNDA
$5.23
-$0.11-1.97%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 170.03M | 202.31M | 263.85M | 293.75M | 325.55M |
| Total Receivables | 59.69M | 56.88M | 54.58M | 50.54M | 44.99M |
| Inventory | 1.68M | 1.70M | 1.85M | 2.04M | 2.17M |
| Prepaid Expenses | 32.98M | 32.18M | 26.88M | 21.16M | 22.21M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 103.00K | 103.00K | 103.00K | -- | -- |
| Total Current Assets | 264.48M | 293.17M | 347.26M | 367.50M | 394.92M |
|
|
|||||
| Total Current Assets | 264.48M | 293.17M | 347.26M | 367.50M | 394.92M |
| Net Property, Plant & Equipment | 23.95M | 14.07M | 13.51M | 11.90M | 12.47M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 113.12M | 115.10M | 117.09M | 108.84M | 110.59M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.92M | 11.19M | 11.08M | 112.90M | 106.76M |
| Total Assets | 412.47M | 433.53M | 488.95M | 601.14M | 624.75M |
|
|
|||||
| Total Accounts Payable | 8.68M | 4.47M | 4.94M | 3.14M | 2.18M |
| Total Accrued Expenses | 56.68M | 50.13M | 47.80M | 39.79M | 50.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.63M | 6.02M | 5.56M | 4.69M | 4.68M |
| Total Finance Division Other Current Liabilities | 94.03M | 74.96M | 86.87M | 70.25M | 64.37M |
| Total Other Current Liabilities | 94.03M | 74.96M | 86.87M | 70.25M | 64.37M |
| Total Current Liabilities | 164.03M | 135.58M | 145.16M | 117.87M | 121.49M |
|
|
|||||
| Total Current Liabilities | 164.03M | 135.58M | 145.16M | 117.87M | 121.49M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 18.20M | 7.05M | 7.07M | 6.23M | 6.96M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.05M | 10.13M | 9.53M | 11.04M | 9.97M |
| Total Liabilities | 192.28M | 152.76M | 161.76M | 135.14M | 138.42M |
|
|
|||||
| Common Stock & APIC | 725.99M | 723.89M | 721.32M | 719.04M | 716.93M |
| Retained Earnings | -505.85M | -443.33M | -394.77M | -253.58M | -230.99M |
| Treasury Stock & Other | 38.00K | 212.00K | 629.00K | 540.00K | 396.00K |
| Total Common Equity | 220.19M | 280.77M | 327.19M | 466.00M | 486.33M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 220.19M | 280.77M | 327.19M | 466.00M | 486.33M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 220.19M | 280.77M | 327.19M | 466.00M | 486.33M |
|
|
|||||